Global site navigation

Barclays bank says CEO has cancer, to remain in post
Business and Economy

Barclays bank says CEO has cancer, to remain in post

by  AFP 1 min read
Venkatakrishnan said his treatment, at Memorial Sloan Kettering Cancer Center in New York, would likely last 12 to 16 weeks
Venkatakrishnan said his treatment, at Memorial Sloan Kettering Cancer Center in New York, would likely last 12 to 16 weeks. Photo: Daniel LEAL / AFP
Source: AFP

PAY ATTENTION: Read YEN News now on Facebook Broadcast Channel. Click and follow now!

British bank Barclays on Monday said its chief executive C.S. Venkatakrishnan is suffering from cancer and will remain in the top post while undergoing treatment.

The lender announced the news in a brief statement alongside a letter by Venkatakrishnan to staff that presented an upbeat prognosis for his non-Hodgkin lymphoma, a cancer affecting the lymph system.

"The good news is that the matter has been detected early, with scans and biopsies confirming it to be very localised," he wrote.

"The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen."

Venkatakrishnan said his treatment, at Memorial Sloan Kettering Cancer Center in New York, would likely last 12 to 16 weeks.

"During this period, the company will run normally, and I will continue to be actively engaged in managing it," he added.

Read also

China arrests BBC journalist covering Covid protests

PAY ATTENTION: Enjoy reading our stories? Join YEN.com.gh's Telegram channel for more!

Barclays last month announced a 10-percent lift in net profit for the third quarter but also revealed rising impairment charges owing to an uncertain economic environment.

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.

Hot: